Medican Enterprises (MDCN) Ratios

48 Followers

Medican Enterprises Ratios

MDCN's free cash flow for Q3 2022 was $0.52. For the 2022 fiscal year, MDCN's free cash flow was decreased by $ and operating cash flow was $0.38. See a summary of the company’s cash flow.

Ratios	TTM	Dec 22	Dec 21	Dec 20
Liquidity Ratios
Current Ratio	0.00	0.00	0.00	0.00
Quick Ratio	0.00	0.00	0.00	0.00
Cash Ratio	0.00	0.00	0.00	0.00
Solvency Ratio	-0.06	0.35	0.04	0.17
Operating Cash Flow Ratio	0.00	0.00	0.00	0.00
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00
Net Current Asset Value	$ -19.74M	$ -19.74M	$ -25.07M	$ -27.85M
Leverage Ratios
Debt-to-Assets Ratio	0.41	0.41	0.58	0.69
Debt-to-Equity Ratio	0.70	0.70	1.41	2.21
Debt-to-Capital Ratio	0.41	0.41	0.58	0.69
Long-Term Debt-to-Capital Ratio	0.41	0.41	0.58	0.69
Financial Leverage Ratio	1.70	1.70	2.41	3.21
Debt Service Coverage Ratio	-0.60	84.75	4.31	9.57
Interest Coverage Ratio	-1.00	8.86	1.55	-0.18
Debt to Market Cap	6.88	5.09K	3.26K	27.62K
Interest Debt Per Share	<0.01	<0.01	<0.01	<0.01
Net Debt to EBITDA	-16.32	2.79	21.10	5.41
Profitability Margins
Gross Profit Margin	0.00%	48.29%	47.89%	19.38%
EBIT Margin	0.00%	246.68%	10.10%	397.10%
EBITDA Margin	0.00%	270.83%	28.03%	465.94%
Operating Profit Margin	0.00%	28.31%	10.10%	-8.81%
Pretax Profit Margin	0.00%	243.46%	3.60%	348.46%
Net Profit Margin	0.00%	243.46%	3.60%	348.46%
Continuous Operations Profit Margin	0.00%	243.46%	3.60%	348.46%
Net Income Per EBT	100.00%	100.00%	100.00%	100.00%
EBT Per EBIT	60.50%	859.93%	35.65%	-3955.78%
Return on Assets (ROA)	-2.51%	13.17%	0.35%	9.50%
Return on Equity (ROE)	-5.20%	22.35%	0.84%	30.52%
Return on Capital Employed (ROCE)	-4.15%	1.53%	0.98%	-0.24%
Return on Invested Capital (ROIC)	-4.15%	1.53%	0.98%	-0.24%
Return on Tangible Assets	-2.51%	13.17%	0.35%	9.50%
Earnings Yield	-29.62%	163101.91%	1959.85%	381150.31%
Efficiency Ratios
Receivables Turnover	0.00	0.00	0.00	0.00
Payables Turnover	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.12	0.24	0.07
Asset Turnover	0.00	0.05	0.10	0.03
Working Capital Turnover Ratio	0.00	11.99	22.03	55.20
Cash Conversion Cycle	0.00	0.00	0.00	0.00
Days of Sales Outstanding	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	0.00	0.00	0.00	0.00
Days of Payables Outstanding	0.00	0.00	0.00	0.00
Operating Cycle	0.00	0.00	0.00	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	>-0.01	<0.01	<0.01	<0.01
Free Cash Flow Per Share	>-0.01	<0.01	<0.01	<0.01
CapEx Per Share	<0.01	<0.01	<0.01	0.00
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	-7.07M	1.49M	303.44K	0.00
Capital Expenditure Coverage Ratio	-7.07M	1.49M	303.44K	0.00
Operating Cash Flow Coverage Ratio	-1.07	0.30	0.05	0.49
Operating Cash Flow to Sales Ratio	0.00	2.29	0.29	12.42
Free Cash Flow Yield	-736.08%	153377.42%	15582.83%	1358843.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-3.38	<0.01	0.05	<0.01
Price-to-Sales (P/S) Ratio	0.00	<0.01	<0.01	<0.01
Price-to-Book (P/B) Ratio	0.14	<0.01	<0.01	<0.01
Price-to-Free Cash Flow (P/FCF) Ratio	-0.14	<0.01	<0.01	<0.01
Price-to-Operating Cash Flow Ratio	-0.19	<0.01	<0.01	<0.01
Price-to-Earnings Growth (PEG) Ratio	-0.03	0.00	>-0.01	0.00
Price-to-Fair Value	0.14	<0.01	<0.01	<0.01
Enterprise Value Multiple	-18.70	2.79	21.11	5.41
Enterprise Value	22.62M	19.75M	25.07M	27.85M
EV to EBITDA	-18.70	2.79	21.11	5.41
EV to Sales	0.00	7.57	5.92	25.23
EV to Free Cash Flow	-1.07	3.31	20.66	2.03
EV to Operating Cash Flow	-1.07	3.31	20.66	2.03
Tangible Book Value Per Share	<0.01	<0.01	<0.01	<0.01
Shareholders’ Equity Per Share	<0.01	<0.01	<0.01	<0.01
Tax and Other Ratios
Effective Tax Rate	0.00	0.00	0.00	0.00
Revenue Per Share	0.00	<0.01	<0.01	<0.01
Net Income Per Share	>-0.01	<0.01	<0.01	<0.01
Tax Burden	1.00	1.00	1.00	1.00
Interest Burden	1.00	0.99	0.36	0.88
Research & Development to Revenue	0.00	0.00	0.00	0.00
SG&A to Revenue	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00
Income Quality	17.54	0.94	7.95	3.57

Currency in USD